SEC Form 4 · accession 0001140361-16-058008
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam Havey
Officer — EVP, Biodefense Divison
Period of report
Mar 14, 2016
Accepted (ET)
Mar 16, 2016 · 3:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Mar 14, 2016 | S | 2,701 | $33.96 | D | 39,163 | D | |
| Common StockF1,F2,F3 | Mar 14, 2016 | S | 1,658 | $33.96 | D | 37,505 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
- F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.67 to $34.17, inclusive.